Skip to Content

135 (Nimodipine 30 mg)

Pill imprint 135 has been identified as Nimodipine 30 mg.

Nimodipine is used in the treatment of subarachnoid hemorrhage; migraine prevention; ischemic stroke and belongs to the drug class calcium channel blocking agents. Risk cannot be ruled out during pregnancy. Nimodipine 30 mg is not a controlled substance under the Controlled Substance Act (CSA).

Nimodipine 30 mg 135
Discount Card Promo
Nimodipine
Imprint:
135
Strength:
30 mg
Color:
Yellow
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Calcium channel blocking agents
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Manufacturer:
Caraco Pharmaceutical Laboratories
National Drug Code (NDC):
57664-0135
Inactive Ingredients:
glycerin
peppermint oil
water
polyethylene glycol
gelatin
D&C Yellow No. 10
titanium dioxide
ammonia
ferrosoferric oxide
butyl alcohol
isopropyl alcohol
shellac
alcohol
propylene glycol
medium-chain triglycerides

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide